Primary cutaneous marginal zone B-cell lymphoma with amyloid deposition: Report of two cases with review of literature

Chinese Journal of Cancer

Volumn 29, Issue 6, 2010, Pages 634-640

  Zhang, Hai Yan ^a   Liu, An Li ^a   Zhou, Ling sheng ^a   He, Miao Xia ^b   Wang, Jian Xin ^b  

^a Nanyang Medical School of Henan Province   (China)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Amyloid deposition; Differential diagnosis; Primary cutaneous marginal zone B cell lymphoma; Recurrence and relapse

Indexed keywords

AMYLOID; CD19 ANTIBODY; CD20 ANTIBODY; CD3 ANTIBODY; CD45 ANTIGEN; CD7 ANTIGEN; CD79A ANTIGEN; IMMUNOGLOBULIN ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN H ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; INTERFERON REGULATORY FACTOR 4; KI 67 ANTIGEN; T LYMPHOCYTE RECEPTOR; T LYMPHOCYTE RECEPTOR GAMMA; UNCLASSIFIED DRUG;

ADULT; AMYLOIDOSIS; ARTICLE; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DIFFERENTIAL DIAGNOSIS; GENE REARRANGEMENT; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MARGINAL ZONE LYMPHOMA; MICROSCOPY; MORPHOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; PARESTHESIA; PHYSICAL EXAMINATION; POLYMERASE CHAIN REACTION; PRIMARY CUTANEOUS MARGINAL ZONE B CELL LYMPHOMA; PROTEIN EXPRESSION; SUBCUTANEOUS TISSUE TUMOR; TUMOR CELL; TUMOR RECURRENCE;

EID: 79955825158     PISSN: 1000467X     EISSN: 1944446X     Source Type: Journal    
DOI: 10.5732/cjc.009.10627     Document Type: Article

References (21)

1. Isaacson P, Wright DH. Malignant lymphoma of mucosa-associated lymphoid tissue, a distinctive type of B-cell lymphoma [J]. Cancer, 1983, 52(8): 1410-1416.
2. Swerdlow SH, Campo E, Harris NL, et al. World Health Organization classification of tumour, pathology and genetics of tumours of haematopoietic and lymphoid tissues. International agency for reseach on cancer [M]. Lyon, France: IARC Press, 2008.
3. Senff NJ, Noordijk EM, Kim YH, et al. European organization for research and treatment of cancer and international society for cutaneous lymphoma consensus recommendations for the management of cutaneous B-cell lymphomas [J]. Blood, 2008, 112(5): 1600-1609.
4. Cho-Vega JH, Vega F, Rassidakis G, et al. Primary cutaneous marginal zone B-cell lymphoma [J]. Am J Clin Pathol, 2006, 125 Suppl: S38-S49.
5. Topalkara A, Ben-Arie-Weintrob Y, Ferry JA, et al. Conjunctival marginal zone B-cell lymphoma (MALT lymphoma) with amyloid and relapse in the stomach [J]. Ocul Immunol Inflamm, 2007, 15(4): 347-350.
6. Trainor KJ, Brisco MJ, Wan JH. et al. Gene rearrangement in B-and T-lymphoproliferative disease detected by the polymerase chain reaction [J]. Blood, 1991, 78(1): 192-196.
7. Gillmore JD, Hawkins PN, Pepys MB. Amyloidosis: a review of recent diagnostic and therapeutic developments [J]. Br J Haematol, 1997, 99(2): 245-256.
8. Goteri G, Ranaldi R, Pileri SA, et al. Localized amyloidosis and gastrointestinal lymphoma: a rare association [J]. Histopathology, 1998, 32 (4): 348-355.
9. Satani T, Yokose T, Kaburagi T, et al. Amyloid deposition in primary pulmonary marginal zone B-cell lymphoma of mucosa-associated lymphoid [J]. Pathol Int, 2007, 57(11): 746-750.
10. Kojima M, Sugihara S, Iijima M, et al. Marginal zone B-cell lymphoma of minor salivary gland representing tumor-forming amyloidosis of the oral cavity: a case report [J]. J Oral Pathol Med, 2006, 35(5): 314-316.
11. Gupta D, Shidham V, Zemba-Palko V, et al. Primary bilateral mucosa-associated lymphoid tissue lymphoma of the breast with atypical ductal hyperplasia and localized amyloidosis: a case report and review of the literature [J]. Arch Pathol Lab Med, 2000, 124(8): 1233-1236.
12. Androulaki A, Giaslakiotis K, Giakoumi X, et al. Localized Castleman's disease associated with systemic AA amyloidosis: regression of amyloid deposits after tumor removal [J]. Ann Hematol, 2007, 86(1): 55-57.
13. Tu PH, Giannini C, Judkins AR, et al. Clinicopathologic and genetic profile of intracranial marginal zone lymphoma: a primary low-grade CNS lymphoma that mimics meningioma [J]. J Clin Oncol. 2005; 23(24): 5718-5727.
14. George AC, Ozsahin M, Janzer R, et al. Primary intracranial dural lymphoma of mucosa-associated lymphoid tissue (MALT) type: report of one case and review of the literature [J]. Bull Cancer, 2005, 92 (7): E51-E56.
15. Saggioro FP, Colli BO, Paix?o-Becker AN, et al. Primary low-grade MALT lymphoma of the dura [J]. Histopathology, 2006, 49(3): 323-326.
16. Thieblemont C, Berger F, Dumontet C, et al. Mucosa-associated lymphoid tissue lymphoma is a disseminated disease in one third of 158 patients analyzed [J]. Blood, 2000, 95(3): 802-806.
17. Raderer M, Vorbeck F, Formanek M, et al. Importance of extensive staging in patients with mucosa-associated lymphoid tissue (MALT)-type lymphoma [J]. Br J Cancer, 2000, 83(4): 454-457.
18. Suh C, Huh J, Roh JL. Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue arising in the extracranial head and neck region: a high rate of dissemination and disease recurrence [J]. Oral Oncol, 2008, 44(10): 949-955.
19. De Boer JP, Hiddink RF, Raderer M, et al. Dissemination patterns in non-gastric MALT lymphoma [J]. Haematologica, 2008, 93(2): 201-206.
20. Drillenburg P, van der Voort R, Koopman G, et al. Preferential expression of the mucosal homing receptor integrin alpha 4 beta 7 in gastrointestinal non-Hodgkin's lymphomas [J]. Am J Pathol, 1997, 150(3): 919-927.
21. Raderer M, Streubel B, Woehrer S, et al. High relapse rate in patients with MALT lymphoma warrants lifelong follow-up [J]. Clin Cancer Res, 2005, 11(9): 3349-3352.